Industry News & Announcements
Industry News & Announcements
With an upfront payment of $100 million, Kyowa Kirin has bought into a partnership with BridgeBio to develop and commercialize Truseltiq (infigratinib) in Japan. Besides the sizable upfront installment, Kyowa Kirin agreed to fork over undisclosed payments if the drug reaches certain milestones, plus pay royalties up to the “high-twenties" in percentage terms.
Kyowa Kirin USA Holdings, Inc.Get Updates
from LSPA
Stay up-to-date on the latest news and events from Life Sciences PA, insights from the life sciences industry, and so much more!
Life Sciences Pennsylvania was founded in 1989 by a biotech scientist at Penn State University. Today it has grown to represent the entire life sciences industry – medical device companies, pharmaceutical companies, investment organizations, research institutions, and myriad service industries that support the life sciences in Pennsylvania.